China's trial approval for the DPYD monoclonal antibody injection by Stone Pharmaceutical Group (01093.HK)

Wisdom Finance and Economics APP News, SinoPharm Group (01093.HK) announced that the Dupilumab injection developed by the group has been approved by the Chinese National Medical Products Administration and can conduct clinical trials in China.